UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Subtyping of triple‐negative breast cancer: Implications for therapy

Cancer, 2015-01, Vol.121 (1), p.8-16

2015

Volltextzugriff (PDF)

TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes

Journal of clinical oncology, 2020-12, Vol.38 (36), p.4274-4282

2020

Volltextzugriff (PDF)

EANM/ESC guidelines for radionuclide imaging of cardiac function

European journal of nuclear medicine and molecular imaging, 2008-04, Vol.35 (4), p.851-885

2008

Volltextzugriff (PDF)

Current Landscape of Targeted Therapies for Hormone-Receptor Positive, HER2 Negative Metastatic Breast Cancer

Frontiers in oncology, 2018-08, Vol.8, p.308-308

2018

Volltextzugriff (PDF)

The bone-muscle connection in breast cancer: implications and therapeutic strategies to preserve musculoskeletal health

Breast cancer research : BCR, 2022-11, Vol.24 (1), p.84-84, Article 84

2022

Volltextzugriff (PDF)

Adjuvant chemotherapy in elderly women with breast cancer (AChEW): an observational study identifying MDT perceptions and barriers to decision making

Annals of oncology, 2013-05, Vol.24 (5), p.1211-1219

2013

Volltextzugriff (PDF)

Exercise as part of survivorship care in metastatic breast cancer: protocol for the randomized EMBody trial

BMC cancer, 2024-09, Vol.24 (1), p.1137-9, Article 1137

2024

Volltextzugriff (PDF)

Impact of Body Mass Index on Presence of ctDNA and Disease Recurrence after Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: Analysis from BRE12-158

Clinical cancer research, 2021-02, Vol.27 (4), p.1195-1199

2021

Volltextzugriff (PDF)

Long-term survival in patients with advanced non–small-cell lung cancer treated with atezolizumab versus docetaxel: Results from the randomised phase III OAK study

European journal of cancer (1990), 2019-01, Vol.107, p.124-132

2019

Volltextzugriff (PDF)

Impact of African ancestry on the relationship between body mass index and survival in an early‐stage breast cancer trial (ECOG‐ACRIN E5103)

Cancer, 2022-06, Vol.128 (11), p.2174-2181

2022

Volltextzugriff (PDF)

[89Zr]Oxinate4 for long-term in vivo cell tracking by positron emission tomography

European journal of nuclear medicine and molecular imaging, 2015-02, Vol.42 (2), p.278-287

2015

Volltextzugriff (PDF)

Atezolizumab in Combination With Carboplatin and Nab-Paclitaxel in Advanced Squamous NSCLC (IMpower131): Results From a Randomized Phase III Trial

Journal of thoracic oncology, 2020-08, Vol.15 (8), p.1351-1360

2020

Volltextzugriff (PDF)

Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer: Preplanned Secondary Analysis of the BRE12-158 Randomized Clinical Trial

JAMA oncology, 2020-09, Vol.6 (9), p.1410

2020

Volltextzugriff (PDF)

Initial Phase I Safety Study of Gedatolisib plus Cofetuzumab Pelidotin for Patients with Metastatic Triple-Negative Breast Cancer

Clinical cancer research, 2022-08, Vol.28 (15), p.3235-3241

2022

Volltextzugriff (PDF)

Cancer patients’ views and understanding of genome sequencing: a qualitative study

Journal of medical genetics, 2020-10, Vol.57 (10), p.671-676

2020

Volltextzugriff (PDF)

Current HER2 Testing Recommendations and Clinical Relevance as a Predictor of Response to Targeted Therapy

Clinical breast cancer, 2015-06, Vol.15 (3), p.171-180

2015

Volltextzugriff (PDF)

Landmark trials in the medical oncology management of metastatic breast cancer

Seminars in oncology, 2021-06, Vol.48 (3), p.246-258

2021

Volltextzugriff (PDF)

From ownership to custodianship of tumor biopsy tissue in genomic testing: a mixed methods study of patient views

The oncologist (Dayton, Ohio), 2024-09, Vol.29 (9), p.e1169-e1179

2024

Volltextzugriff (PDF)

A Personalized, Dynamic Physical Activity Intervention Is Feasible and Improves Energetic Capacity, Energy Expenditure, and Quality of Life in Breast Cancer Survivors

Frontiers in oncology, 2021-04, Vol.11, p.626180-626180

2021

Volltextzugriff (PDF)

Impact of Muscle Measures on Outcome in Patients Receiving Endocrine Therapy for Metastatic Breast Cancer: Analysis of ECOG-ACRIN E2112

Journal of the National Comprehensive Cancer Network, 2023-09, Vol.21 (9), p.915-923.e1

2023

Volltextzugriff (PDF)

Patient‐reported outcomes in the Translational Breast Cancer Research Consortium

Cancer, 2020-03, Vol.126 (5), p.922-930

2020

Volltextzugriff (PDF)

ECOG-ACRIN EAZ171: Prospective Validation Trial of Germline Predictors of Taxane-Induced Peripheral Neuropathy in Black Women With Early-Stage Breast Cancer

Journal of clinical oncology, 2024-08, Vol.42 (24), p.2899-2907

2024

Volltextzugriff (PDF)

ASPiRATION: Australian observational cohort study of comprehensive genomic profiling in metastatic lung cancer tissue

Future oncology (London, England), 2024-03, Vol.20 (7), p.361-371

2024

Volltextzugriff (PDF)

Racial Disparities in Breast Cancer: from Detection to Treatment

Current oncology reports, 2024, Vol.26 (1), p.10-20

2024

Volltextzugriff (PDF)

1 – 25 von 82

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(80)
Mit Volltextzugriff
(69)

Publikationsform

Artikel
(82)

Sprache

Englisch
(82)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(80)
Science & Technology
(80)
Humans
(68)
Female
(47)
Middle Aged
(28)
Adult
(24)
Breast Cancer
(22)
Aged
(21)
Male
(18)
Medicine
(16)
Medicine & Public Health
(16)
Cancer
(13)
Radiology, Nuclear Medicine & Medical Imaging
(13)
Biological And Medical Sciences
(12)
Radiology
(12)
Imaging
(11)
Medical Sciences
(11)
Nuclear Medicine
(11)
Orthopedics
(11)

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Subtyping of triple‐negative breast cancer: Implications for therapy

TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes

EANM/ESC guidelines for radionuclide imaging of cardiac function

Current Landscape of Targeted Therapies for Hormone-Receptor Positive, HER2 Negative Metastatic Breast Cancer

The bone-muscle connection in breast cancer: implications and therapeutic strategies to preserve musculoskeletal health

Adjuvant chemotherapy in elderly women with breast cancer (AChEW): an observational study identifying MDT perceptions and barriers to decision making

Exercise as part of survivorship care in metastatic breast cancer: protocol for the randomized EMBody trial

Impact of Body Mass Index on Presence of ctDNA and Disease Recurrence after Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: Analysis from BRE12-158

Long-term survival in patients with advanced non–small-cell lung cancer treated with atezolizumab versus docetaxel: Results from the randomised phase III OAK study

Impact of African ancestry on the relationship between body mass index and survival in an early‐stage breast cancer trial (ECOG‐ACRIN E5103)

[89Zr]Oxinate4 for long-term in vivo cell tracking by positron emission tomography

Atezolizumab in Combination With Carboplatin and Nab-Paclitaxel in Advanced Squamous NSCLC (IMpower131): Results From a Randomized Phase III Trial

Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer: Preplanned Secondary Analysis of the BRE12-158 Randomized Clinical Trial

Initial Phase I Safety Study of Gedatolisib plus Cofetuzumab Pelidotin for Patients with Metastatic Triple-Negative Breast Cancer

Cancer patients’ views and understanding of genome sequencing: a qualitative study

Current HER2 Testing Recommendations and Clinical Relevance as a Predictor of Response to Targeted Therapy

Landmark trials in the medical oncology management of metastatic breast cancer

From ownership to custodianship of tumor biopsy tissue in genomic testing: a mixed methods study of patient views

A Personalized, Dynamic Physical Activity Intervention Is Feasible and Improves Energetic Capacity, Energy Expenditure, and Quality of Life in Breast Cancer Survivors

Impact of Muscle Measures on Outcome in Patients Receiving Endocrine Therapy for Metastatic Breast Cancer: Analysis of ECOG-ACRIN E2112

Patient‐reported outcomes in the Translational Breast Cancer Research Consortium

ECOG-ACRIN EAZ171: Prospective Validation Trial of Germline Predictors of Taxane-Induced Peripheral Neuropathy in Black Women With Early-Stage Breast Cancer

BRE12-158: A Postneoadjuvant, Randomized Phase II Trial of Personalized Therapy Versus Treatment of Physician's Choice for Patients With Residual Triple-Negative Breast Cancer

ASPiRATION: Australian observational cohort study of comprehensive genomic profiling in metastatic lung cancer tissue

Racial Disparities in Breast Cancer: from Detection to Treatment

Aktive Filter

Suchergebnisse filtern